74 related articles for article (PubMed ID: 19840458)
1. [Expression of pituitary tumor transforming gene and C-myc gene in patients with multiple myeloma].
Li DQ; Chen P; Shao JH; Dong XB; Chang YL; Zhao HY; Zhou YW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1238-41. PubMed ID: 19840458
[TBL] [Abstract][Full Text] [Related]
2. [Expression of pituitary tumor-transforming gene in patients with multiple myeloma].
Wang Z; Lu QY; Chen P; Zhang P; Cong YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1143-5. PubMed ID: 17204181
[TBL] [Abstract][Full Text] [Related]
3. [Expression of pituitary tumor transforming gene in patients with AML].
Wang Z; Lu QY; Niu XQ; Zhang P; Zhao JN; Zhang KJ; Li P; Hu JS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1427-30. PubMed ID: 21176344
[TBL] [Abstract][Full Text] [Related]
4. Aberrant translational control of the c-myc gene in multiple myeloma.
Paulin FE; West MJ; Sullivan NF; Whitney RL; Lyne L; Willis AE
Oncogene; 1996 Aug; 13(3):505-13. PubMed ID: 8760292
[TBL] [Abstract][Full Text] [Related]
5. Elevated c-myc messenger RNA in multiple myeloma cell lines.
Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
[TBL] [Abstract][Full Text] [Related]
6. [Regulation of c-myc expression by Blimp-1 during the differentiation of myeloma cells].
Zhou X; Zhou F; Jiang H; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):318-22. PubMed ID: 17877160
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.
Ikeguchi M; Hirooka Y
Pathobiology; 2004; 71(5):281-6. PubMed ID: 15459488
[TBL] [Abstract][Full Text] [Related]
8. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
[TBL] [Abstract][Full Text] [Related]
9. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
10. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
11. The pituitary tumor transforming gene 1 (PTTG-1): an immunological target for multiple myeloma.
Chiriva-Internati M; Ferrari R; Prabhakar M; Yu Y; Baggoni L; Moreno J; Gagliano N; Portinaro N; Jenkins MR; Frezza EE; Hardwicke F; D'Cunha N; Kast W; Cobos E
J Transl Med; 2008 Apr; 6():15. PubMed ID: 18384692
[TBL] [Abstract][Full Text] [Related]
12. hTERT expression in sporadic renal cell carcinomas.
Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
[TBL] [Abstract][Full Text] [Related]
13. c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma.
Aref S; Fouda M; El-Dosoky E; Menessy A; Mabed M; Saleeb M; Zalata K
Hematology; 2003 Jun; 8(3):183-90. PubMed ID: 12745652
[TBL] [Abstract][Full Text] [Related]
14. [Expression of pituitary tumor transforming gene in patients with acute lymphoblastic leukemia].
Wang Z; Lu QY; Niu XQ; Zhang P; Zhang KJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):835-8. PubMed ID: 23998569
[TBL] [Abstract][Full Text] [Related]
15. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
[TBL] [Abstract][Full Text] [Related]
16. The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma.
Jin Y; Yu X; Du J; Li H; Tang W; Jia C; Zan Y; Chen M; Zhang Y; Yu M; Rong W; Zhou D; Zhuang J
Ann Hematol; 2021 May; 100(5):1251-1260. PubMed ID: 33686491
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-alpha, bcl-2 and c-myc gene expression in fibroadenomas and adjacent normal breast: association with nodule size, hormonal and reproductive features.
Cericatto R; Pozzobon A; Morsch DM; Menke CH; Brum IS; Spritzer PM
Steroids; 2005 Mar; 70(3):153-60. PubMed ID: 15763593
[TBL] [Abstract][Full Text] [Related]
18. [Expression of c-myc and c-myb gene in leukemic bone marrow stromal cells and their correlation].
Zhang Y; Chen R; Zhang W; Li J; Chen X; Zhao L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):531-5. PubMed ID: 22739149
[TBL] [Abstract][Full Text] [Related]
19. Transforming events in thyroid tumorigenesis and their association with follicular lesions.
Heaney AP; Nelson V; Fernando M; Horwitz G
J Clin Endocrinol Metab; 2001 Oct; 86(10):5025-32. PubMed ID: 11600580
[TBL] [Abstract][Full Text] [Related]
20. c-myc mRNA expression in minor salivary glands of patients with Sjögren's syndrome.
Skopouli FN; Kousvelari EE; Mertz P; Jaffe ES; Fox PC; Moutsopoulos HM
J Rheumatol; 1992 May; 19(5):693-9. PubMed ID: 1613697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
